Associations Between Metabolic Syndrome and Long-Term Mortality in Patients who underwent Percutaneous Coronary Intervention: An Australian Cohort Analysis
Authors:
- 4 March 2024
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 219, 25-34
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Impact of High-Density Lipoprotein Levels on Cardiovascular Outcomes of Patients Undergoing Percutaneous Coronary Intervention With Drug-Eluting StentsThe American Journal of Cardiology, 2020
- Association of Second-Generation Drug-Eluting Stent Length With 2-Year Adverse Clinical Outcomes Among Japanese Patients With Ischemic Heart DiseaseJAMA Network Open, 2020
- Impact of insulin treated and non‐insulin‐treated diabetes compared to patients without diabetes on 1‐year outcomes following contemporary PCICatheterization and Cardiovascular Interventions, 2020
- The Impact of Metabolic Syndrome on Clinical Outcomes After Everolimus-Eluting Stent ImplantationThe American Journal of Cardiology, 2015
- Impact of Drug Eluting Stent Length on Outcomes of Percutaneous Coronary Intervention (from the EVENT Registry)The American Journal of Cardiology, 2012
- Progress Towards a National Cardiac Procedure Database—Development of the Australasian Society of Cardiac and Thoracic Surgeons (ASCTS) and Melbourne Interventional Group (MIG) RegistriesHeart, Lung and Circulation, 2011
- The Metabolic Syndrome, Its Component Risk Factors, and Progression of Coronary AtherosclerosisArchives of internal medicine (1960), 2010
- Metabolic Syndrome and Risk of Incident Cardiovascular Events and DeathJACC, 2007
- The Foundation and Launch of the Melbourne Interventional Group: A Collaborative Interventional Cardiology ProjectHeart, Lung and Circulation, 2006
- Impact of body mass index on In-Hospital outcomes following percutaneous coronary intervention (report from the New York State Angioplasty Registry)11*This study was performed with the permission of the New York State Department of Health, which retains ownership of the registry.The American Journal of Cardiology, 2004